Newland Pharmaceutical is a Manufacturer/Innovator company operating in the pharmaceutical industry.
Henan Xintiandi Pharmaceutical Co was established in 2005 with a registered capital of 99 million yuan, the existing assets of 300 million yuan. and is mainly engaged in pharmaceutical intermediates, fine chemicals R & D, production and sales. Our leading products Hydroxyphenylglycine L, L-hydroxyphenylglycine Deng salt of Science and Technology Department of Henan Province have been identified as high-tech products, the project was included in the first and second batch of high-tech industrialization projects Henan provincial government.
Company type
Manufacturer/Innovator
Products and services
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
Newland Pharmaceutical, Eastside of Weiwu Road(South Section), CHANGGE, Henan, China, 461500